PETER ROBINS WATSON MD NPI 1376528687

NPI Information

  • NPI: 1376528687
  • Provider Name: PETER ROBINS WATSON, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 313 AIRPORT RD
    KINSTON, NC
    ZIP 28501
  • Phone: (252) 559-2201

Map and Directions

Get Directions

NPI Details

Peter Robins Watson, MD is a medical oncology internal medicine in Kinston, NC with 42 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Peter Robins Watson, MD NPI is 1376528687. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:1983

The provider's business location address is:

313 AIRPORT RD
KINSTON, NC
ZIP 28501
Phone: (252) 559-2201
Fax: (252) 559-2219

The NPI 1376528687 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Magnesium level (HCPCS:83735)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Folic acid level, rbc (HCPCS:82747)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Blood test, clotting time (HCPCS:85610)
  • Iron binding capacity (HCPCS:83550)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Unclassified drugs (HCPCS:J3490)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Automated urinalysis test (HCPCS:81003)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Screening 3d breast mammography (HCPCS:77063)
  • Screening mammography (HCPCS:77067)

The enumeration date for this NPI number is 12/8/2005 and was last updated on 9/14/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology28446NORTH CAROLINAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1110038739OTHERRAILROAD MEDICARE
28985999MEDICAIDNORTH CAROLINA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.